CrowdPharm Named MM+M Best Places to Work 2023

Share

KANSAS CITY, MO – December 7, 2023 – CrowdPharm, a Spectrum Science company, was officially selected as one of MM+M’s Best Places to Work 2023. Click here to read CrowdPharm’s Best Places to Work profile in the December issue.

Now in its sixth year, MM+M’s Best Places to Work highlights some of the most prominent, progressive agencies in the medical marketing industry. Best Places to Work winners demonstrate how successful companies stand out for their commitments to enriching the professional lives of their employees through effective teamwork, inspiring leadership, and career growth opportunities.

In MM+M’s Best Places to Work podcast, judges believed employees were less scripted in their responses than in years past. They also picked up on how companies described being a best place to work and how closely employees’ responses supported those descriptions.

This year, the shift to flexible work environments and arrangements, employee well-being, and encouragement of work/life balance, which have become firmly embedded into company cultures, is what stood out for the judges who evaluated 70+ nominations vying for the 12 recognition opportunities. As MM+M’s Editor-in-Chief Larry Dobrow highlights in December’s Editor’s Desk, “To be one of MM+M’s Best Places to Work, it helps to be, well, a best place to work.”

About CrowdPharm
CrowdPharm, a Spectrum Science company, is a full-service advertising agency led by industry veterans and fueled by the largest network of global talent anywhere. Innovative technology enables the agency to deliver an abundance of original strategic and creative solutions across time zones and provide a flexible force of talent with experience that spans startups, orphan products, blockbusters, and primary care. With 8,500+ members across 128+ countries, the agency is ready to develop compelling brand communications in healthcare, medical, and pharmaceutical marketing for pharmaceutical and biopharma companies. Visit crowdpharm.com.

For more information, contact:
Lori Goodale
VP, Director of Marketing and Corporate Communications
518.366.7230
lorigoodale@crowdpharm.com

More posts
CrowdPharm Announces Appointment and Promotion
Read more >
Ray Colon Named One of the 2024 PM360 ELITE 100
Read more >
New Artist-Protecting Technology Helps Fight Against Copyright Violation
Read more >
See more